IQVIA SG&A increased by 7.3% to $502.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.2%, from $508.00M to $502.00M. Over 4 years (FY 2021 to FY 2025), SG&A shows relatively stable performance with a 0.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrativeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $482.00M | $498.00M | $542.00M | $488.00M | $483.00M | $517.00M | $583.00M | $513.00M | $482.00M | $502.00M | $556.00M | $508.00M | $509.00M | $522.00M | $453.00M | $508.00M | $509.00M | $514.00M | $468.00M | $502.00M |
| QoQ Change | — | +3.3% | +8.8% | -10.0% | -1.0% | +7.0% | +12.8% | -12.0% | -6.0% | +4.1% | +10.8% | -8.6% | +0.2% | +2.6% | -13.2% | +12.1% | +0.2% | +1.0% | -8.9% | +7.3% |
| YoY Change | — | — | — | — | +0.2% | +3.8% | +7.6% | +5.1% | -0.2% | -2.9% | -4.6% | -1.0% | +5.6% | +4.0% | -18.5% | +0.0% | +0.0% | -1.5% | +3.3% | -1.2% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Commercial Solutions | — | — | — | — | — | — | — | $252.00M |
| Research & Development Solutions | $223.00M | $222.00M | $215.00M | $216.00M | $227.00M | $232.00M | $224.00M | $250.00M |
| Contract Sales & Medical Solutions | $15.00M | $14.00M | $15.00M | $14.00M | $14.00M | $15.00M | $17.00M | — |
| Technology & Analytics Solutions | $225.00M | $227.00M | $236.00M | $237.00M | $230.00M | $247.00M | $241.00M | — |
| Total | $509.00M | $522.00M | $453.00M | $508.00M | $509.00M | $514.00M | $468.00M | $502.00M |
Contract Sales & Medical Solutions, Technology & Analytics Solutions were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
SG&A at Other Companies
Frequently Asked Questions
- What is IQVIA's sg&a?
- IQVIA (IQV) reported sg&a of $502.00M in Q1 2026.
- How has IQVIA's sg&a changed year-over-year?
- IQVIA's sg&a decreased by 1.2% year-over-year, from $508.00M to $502.00M.
- What is the long-term trend for IQVIA's sg&a?
- Over 4 years (2021 to 2025), IQVIA's sg&a has grown at a 0.4% compound annual growth rate (CAGR), from $1.96B to $2.00B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.